[1] Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology,2002,35(1):140-148. [2] Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology,2012,55(5):1551-1561. [3] Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol,2014,60(6):1310-1324. [4] Arvaniti V, D’Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology,2010,139(4):1246-1256,1256.e1241-1245. [5] Struck J, Tao C, Morgenthaler Ng, et al. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides,2004,25(8): 1369-1372. [6] Christ-Crain M, Morgenthaler NG, Struck J, et al. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care,2005,9(6):R816-R824. [7] 徐小元,丁惠国,李文刚,等.肝硬化诊治指南.实用肝脏病杂志,2019,22(6):770-786. [8] Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg,1973,60(8):646-649. [9] Kamath PS, Kim WR. Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology,2007,45(3),797-805. [10] Jalan R, Saliba F, Pavesi M, et al. Development and validation of a prognostic score to predict mortality in patients with acute on chronic liver failure. J Hepatol,2014,61(5):1038-1047. [11] 中华人民共和国卫生部.医院感染诊断标准(试行).中华医学杂志,2001,81(5):314-320. [12] Hirata Y, Mitaka C, Sato K, et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab,1996,81(4): 1449-1453. [13] Hinson JP, Kapas S, Smith DM. Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev,2000,21(2): 138-167. [14] Andaluz-Ojeda D,Nguyen HB,Meunier-Beillard N,et al. Superior accuracy of mid-regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Ann Intens Care,2017,7(1): 15-22. [15] Al Shuaibi M, Bahu RR, Chaftari AM, et al. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. Clin Infect Dis,2013,56(7):943-950. [16] Uberviola B, Castellanos-Ortega A, Ruiz Ruiz A, et al. Hospital mortality prognostication in sepsis using the new biomarkers suPAR and pro-ADM in a single determination on ICU admission. Intensive Care Med,2013,39(11):1945-1952. [17] Linscheid P, Seboek D, Zulewski H, et al. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology,2005,146(6):2699-2708. [18] Eto T, Kato J, Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept,2003,112:61-69. [19] Devière J, Content J, Denys C, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology,1990,11(4): 628-634. [20] Fukui H, Brauner B, Bode JC, et al. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol,1991,12(2): 162-169. [21] Ishimitsu T, Nishikimi T, Saito Y, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest,1994,94(5): 2158-2161. |